Adam C. Derbyshire is EVP Finance/CFO at SALIX PHARMACEUTICALS LTD (SLXP). They have made 3 open-market trades across 1 company since 2007, most recently 2014-08-22.
CIK 0001212669
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $20K since 2007, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLXP | 218,463 | — |
Shares reported on the most recent Form 4, priced at the 2014-08-26 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLXP | SELL · 10b5-1 | 2014-01-09 | 2014-01-13 | $91.48 | $2.7M | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2012-12-26 | 2012-12-28 | $41.44 | $2.5M | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2012-02-28 | 2012-03-01 | $50.09 | $631K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2012-02-13 | 2012-02-15 | $50.00 | $645K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2012-02-03 | 2012-02-07 | $50.00 | $39K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2012-01-18 | 2012-02-07 | $50.00 | $19K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2012-01-17 | 2012-01-19 | $45.44 | $170K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-12-09 | 2009-12-11 | $23.10 | $116K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-12-02 | 2009-12-02 | $23.37 | $117K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-11-25 | 2009-11-30 | $23.58 | $118K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-11-18 | 2009-11-19 | $21.05 | $105K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-11-11 | 2009-11-13 | $20.12 | $101K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-11-04 | 2009-11-06 | $19.70 | $98K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-10-28 | 2009-10-29 | $19.79 | $99K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-10-21 | 2009-10-23 | $21.00 | $105K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-10-14 | 2009-10-14 | $22.89 | $114K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-10-07 | 2009-10-08 | $23.89 | $119K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-09-30 | 2009-10-01 | $21.04 | $105K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-09-23 | 2009-09-24 | $20.73 | $104K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-09-16 | 2009-09-16 | $19.80 | $99K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-09-09 | 2009-09-09 | $12.92 | $65K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-09-02 | 2009-09-04 | $12.23 | $37K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-08-28 | 2009-09-01 | $12.66 | $38K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-08-25 | 2009-08-27 | $12.83 | $38K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2009-08-20 | 2009-08-24 | $12.74 | $38K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.